The role of TERT promoter mutations in postoperative and preoperative diagnosis and prognosis in thyroid cancer

被引:44
作者
Jin, Anqi [1 ,2 ]
Xu, Jianhao [2 ]
Wang, Yan [3 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Inst Ultrasound Med, Dept Ultrasound Med, Med Reading,Affiliated Peoples Hosp 6, Shanghai, Peoples R China
[2] Soochow Univ, Med Coll, Suzhou, Peoples R China
[3] Shanghai Jiao Tong Univ, Dept Ultrasound Med, Affiliated Peoples Hosp 6, Shanghai Inst Ultrasound Med, Shanghai, Peoples R China
关键词
FNA; TERT; thyroid cancer; BRAF V600E; HIGH PREVALENCE; DISTANT METASTASES; MAJOR INDICATOR; CARCINOMA; TELOMERASE; PREDICTION; HTERT; GENE;
D O I
10.1097/MD.0000000000011548
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Telomerase reverse transcriptase (TERT) promoter mutations have been described in different pathological types of thyroid cancers (TC). After many types of research focusing on the mutations rate in malignant tumors, the main role of TERT promoter mutations has been changed to the preoperative diagnosis and prognosis of TC, according to their high prevalence in aggressive TC. Methods: We searched Pubmed, Web of Science, Scopus, and VHL and reviewed the most common 2 mutations C288T and C250T in different types of TC, the association between them and some specific clinicopathological features, and their significance in preoperative diagnosis and prognosis of TC. we chose 38 studies into our qualitative research. We also chose 22 studies to do a meta-analysis on this subject. Results: The overall rate of these mutations in different types of TC was 10.0%, with 86.1% C228T mutation, 12% C250T mutation, and 2.1% other type mutations. The rate increases significantly as the TC become more aggressive, and reaches 56.8% in anaplastic thyroid cancer (ATC). Statistically meaningful association is found between TERT promoter mutations and older age, larger tumor size, extrathyroidal extension, lymph node metastasis, distance metastasis, advanced TNM stage, recurrence, and BRAF V600E mutation. Some studies concentrating on DNA sequencing based on fine needle aspiration biopsy (FNAB) also proved their significance in preoperative stage, with 7% to 16.5% sensitivity. Conclusions: TERT promoter mutations were likely to occur in BRAF V600E positive TC. Patients with these 2 combined mutations were more likely to have a poor prognosis and outcome. TERT promoter mutations is an essential part of the ThySeq gene panel. The mechanism of how they influence the appearance and development of TC has not been expounded. The next study direction may be the mechanism exploration and the further study to prove their significance in preoperative diagnosis.
引用
收藏
页数:6
相关论文
共 43 条
[11]   Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT [J].
Dettmer, Matthias S. ;
Schmitt, Anja ;
Steinert, Hans ;
Capper, David ;
Moch, Holger ;
Komminoth, Paul ;
Perren, Aurel .
ENDOCRINE-RELATED CANCER, 2015, 22 (03) :419-429
[12]   BRAF mutations in papillary carcinomas of the thyroid [J].
Fukushima, T ;
Suzuki, S ;
Mashiko, M ;
Ohtake, T ;
Endo, Y ;
Takebayashi, Y ;
Sekikawa, K ;
Hagiwara, K ;
Takenoshita, S .
ONCOGENE, 2003, 22 (41) :6455-6457
[13]   TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma [J].
Gandolfi, Greta ;
Ragazzi, Moira ;
Frasoldati, Andrea ;
Piana, Simonetta ;
Ciarrocchi, Alessia ;
Sancisi, Valentina .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2015, 172 (04) :403-413
[14]   Telomeres [J].
Greider, Carol W. .
CURRENT OPINION IN CELL BIOLOGY, 1991, 3 (03) :444-451
[15]   The Role of Telomeres in Stem Cells and Cancer [J].
Guenes, Cagatay ;
Rudolph, K. Lenhard .
CELL, 2013, 152 (03) :390-393
[16]   SERIAL CULTIVATION OF HUMAN DIPLOID CELL STRAINS [J].
HAYFLICK, L ;
MOORHEAD, PS .
EXPERIMENTAL CELL RESEARCH, 1961, 25 (03) :585-+
[17]   Low Prevalence of Somatic TERT Promoter Mutations in Classic Papillary Thyroid Carcinoma [J].
Jeon, Min Ji ;
Kim, Won Gu ;
Sim, Soyoung ;
Lim, Seonhee ;
Kwon, Hyemi ;
Kim, Tae Yong ;
Shong, Young Kee ;
Kim, Won Bae .
ENDOCRINOLOGY AND METABOLISM, 2016, 31 (01) :100-104
[18]   BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients [J].
Jin, Langping ;
Chen, Endong ;
Dong, Siyang ;
Cai, Yefeng ;
Zhang, Xiangjian ;
Zhou, Yili ;
Zeng, Ruichao ;
Yang, Fan ;
Pan, Chuanmeng ;
Liu, Yehuan ;
Wu, Weili ;
Xing, Mingzhao ;
Zhang, Xiaohua ;
Wang, Ouchen .
ONCOTARGET, 2016, 7 (14) :18346-18355
[19]   Ultrasonographic prediction of highly aggressive telomerase reverse transcriptase (TERT) promoter-mutated papillary thyroid cancer [J].
Kim, Tae Hyuk ;
Ki, Chang-Seok ;
Hahn, Soo Yeon ;
Oh, Young Lyun ;
Jang, Hye Won ;
Kim, Sun Wook ;
Chung, Jae Hoon ;
Shin, Jung Hee .
ENDOCRINE, 2017, 57 (02) :234-240
[20]   TERT promoter mutations and long-term survival in patients with thyroid cancer [J].
Kim, Tae Hyuk ;
Kim, Young-Eun ;
Ahn, Soomin ;
Kim, Ji-Youn ;
Ki, Chang-Seok ;
Oh, Young Lyun ;
Kim, Kyunga ;
Yun, Jae Won ;
Park, Woong-Yang ;
Choe, Jun-Ho ;
Kim, Jung-Han ;
Kim, Jee Soo ;
Kim, Sun Wook ;
Chung, Jae Hoon .
ENDOCRINE-RELATED CANCER, 2016, 23 (10) :813-823